Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "L04AA" (158)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
What is an ATC-Code?
ATC-Overview
Antilymphocyte Immunoglobulin (Horse) (L04AA03) 1 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
L
IP
V/S
Atgam 250 mg/5 ml
5 x 5 ml
2797.16
3058.50
10 %
Concentrate for infusion: Immunoglobulinum Anti-T Limphocytorum ex Equus 50 mg
Pfizer AG
A / SL
FB
G
Antithymocyte Immunoglobulin (Rabbit) (L04AA04) 4 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
L
IP
V/S
GRAFALON
Durchstechflasche(n)
372.42
421.45
10 %
Concentrate for infusion: Immunoglobulinum Anti-T Limphocytorum ex Cuniculus 20 mg/ml
Neovii
Pharmaceuticals AG
B / SL
FB
G
L
IP
V/S
GRAFALON
10 Durchstechflasche(n)
3718.42
4060.40
10 %
Concentrate for infusion: Immunoglobulinum Anti-T Limphocytorum ex Cuniculus 20 mg/ml
Neovii
Pharmaceuticals AG
B / SL
FB
G
IP
V/S
Thymoglobuline
Durchstechflasche(n)
k.A.
poudre pour solution à diluer pour perfusion: Immunoglobulinum Anti-T Limphocytorum ex Cuniculus 25 mg
Sanofi-Aventis
(Suisse) SA
B
FB
G
IP
Atgam
5 x 5 ml
2005.60
k.A.
Injection solution: Immunoglobulinum Antithymocyticum Equi 250 mg
Pharmacia AG
B
FB
G
Mycophenolic Acid (L04AA06) 40 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Cellcept 500 mg
-
T
50 Tablet(s)
90.85
115.20
20 %
Coated tablets: Mofetili Mycophenolas 500 mg
Roche Pharma
(Schweiz) AG
B / SL / SO
FB
G
IP
CI
Cellcept 500 mg
-
T
150
272.56
308.65
20 %
Coated tablets: Mofetili Mycophenolas 500 mg
Roche Pharma
(Schweiz) AG
B / SL / SO
FB
G
IP
CI
Cellcept 250 mg
100 Capsule(s)
99.23
124.35
20 %
Capsules: Mofetili Mycophenolas 250 mg
Roche Pharma
(Schweiz) AG
B / SL / SO
FB
G
IP
CI
Cellcept 250 mg
300
297.69
335.60
20 %
Capsules: Mofetili Mycophenolas 250 mg
Roche Pharma
(Schweiz) AG
B / SL / SO
FB
G
IP
CI
Mycophenolat-Mofetil
Sandoz 500 mg
150 Tablet(s)
204.42
238.75
10 %
Coated tablets: Mofetili Mycophenolas 500 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Myfenax 500 mg
3 x 50
204.42
238.75
10 %
Coated tablets: Mofetili Mycophenolas 500 mg
Teva Pharma AG
B / SL / SG
FB
G
IP
CI
Mycophenolat-Mofetil
Sandoz
300 Capsule(s)
223.27
259.25
10 %
Capsules: Mofetili Mycophenolas 250 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Myfenax 250 mg
3 x 100
223.28
259.25
10 %
Capsules: Mofetili Mycophenolas 250 mg
Teva Pharma AG
B / SL / SG
FB
G
L
IP
CI
Cellcept
Flasche(n) à 35 g
148.18
177.55
10 %
Pulver zur Herstellung einer Suspension zum Einnehmen: Mofetili Mycophenolas 200 mg
Roche Pharma
(Schweiz) AG
B / SL
FB
G
IP
CI
Myfortic 180 mg
120 Tablet(s)
125.48
152.90
10 %
magensaftresistente Filmtabletten: Acidum Mycophenolicum 180 mg
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
Myfortic 360 mg
120 Tablet(s)
229.66
266.20
10 %
magensaftresistente Filmtabletten: Acidum Mycophenolicum 360 mg
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
Cellcept i.v.
4 Durchstechflasche(n)
184.30
k.A.
Lyophilisate: Mofetili Mycophenolas 500 mg
Roche Pharma
(Schweiz) AG
B
FB
G
IP
CI
Cellcept 500 mg
-
T
150
371.07
442.40
k.A.
Coated tablets: Mofetili Mycophenolas 500 mg
Roche Pharma
(Schweiz) AG
B
FB
G
IP
CI
Cellcept 250 mg
300
405.28
481.65
k.A.
Capsules: Mofetili Mycophenolas 250 mg
Roche Pharma
(Schweiz) AG
B
FB
G
IP
CI
Cellcept 500 mg
50
74.96
97.95
10 %
Coated tablets: Mofetili Mycophenolas 500 mg
APS-Arzneimittel-
Parallelimport-
Service AG
B / SL / SO
FB
G
IP
CI
Cellcept 500 mg
150
224.86
259.70
10 %
Coated tablets: Mofetili Mycophenolas 500 mg
APS-Arzneimittel-
Parallelimport-
Service AG
B / SL / SO
FB
G
IP
CI
Cellcept 500 mg
150
224.86
259.70
10 %
Coated tablets: Mofetili Mycophenolas 500 mg
APS-Arzneimittel-
Parallelimport-
Service AG
B / SL / SO
FB
G
IP
CI
Cellcept 250 mg
100
81.88
105.45
10 %
Capsules: Mofetili Mycophenolas 250 mg
APS-Arzneimittel-
Parallelimport-
Service AG
B / SL / SO
FB
G
IP
CI
Cellcept 250 mg
300
245.59
282.15
10 %
Capsules: Mofetili Mycophenolas 250 mg
APS-Arzneimittel-
Parallelimport-
Service AG
B / SL / SO
FB
G
IP
CI
Cellcept 250 mg
300
245.59
282.15
10 %
Capsules: Mofetili Mycophenolas 250 mg
APS-Arzneimittel-
Parallelimport-
Service AG
B / SL / SO
FB
G
IP
CI
Cellcept 500 mg
50
k.A.
Coated tablets: Mofetili Mycophenolas 500 mg
APS-Arzneimittel-
Parallelimport-
Service AG
B
FB
G
IP
CI
Cellcept 500 mg
50
k.A.
Coated tablets: Mofetili Mycophenolas 500 mg
APS-Arzneimittel-
Parallelimport-
Service AG
B
FB
G
IP
CI
Cellcept 500 mg
50
k.A.
Coated tablets: Mofetili Mycophenolas 500 mg
APS-Arzneimittel-
Parallelimport-
Service AG
B
FB
G
CellCept 500 mg
50
k.A.
Coated tablets: Mofetili Mycophenolas 500 mg
DIFARMED AG
B
FB
G
IP
CI
Cellcept 500 mg
150
k.A.
Coated tablets: Mofetili Mycophenolas 500 mg
APS-Arzneimittel-
Parallelimport-
Service AG
B
FB
G
IP
CI
Cellcept 500 mg
150
k.A.
Coated tablets: Mofetili Mycophenolas 500 mg
APS-Arzneimittel-
Parallelimport-
Service AG
B
FB
G
IP
CI
Cellcept 500 mg
150
k.A.
Coated tablets: Mofetili Mycophenolas 500 mg
APS-Arzneimittel-
Parallelimport-
Service AG
B
FB
G
IP
CI
Cellcept 500 mg
150
k.A.
Coated tablets: Mofetili Mycophenolas 500 mg
APS-Arzneimittel-
Parallelimport-
Service AG
B
FB
G
IP
CI
Cellcept 500 mg
150
k.A.
Coated tablets: Mofetili Mycophenolas 500 mg
APS-Arzneimittel-
Parallelimport-
Service AG
B
FB
G
IP
CI
Cellcept 500 mg
150
k.A.
Coated tablets: Mofetili Mycophenolas 500 mg
APS-Arzneimittel-
Parallelimport-
Service AG
B
FB
G
CellCept 250 mg
100
k.A.
Capsules: Mofetili Mycophenolas
DIFARMED AG
B
FB
G
IP
CI
Cellcept 250 mg
100
k.A.
Capsules: Mofetili Mycophenolas 250 mg
APS-Arzneimittel-
Parallelimport-
Service AG
B
FB
G
IP
CI
Cellcept 250 mg
100
k.A.
Capsules: Mofetili Mycophenolas 250 mg
APS-Arzneimittel-
Parallelimport-
Service AG
B
FB
G
IP
CI
Cellcept 250 mg
100
k.A.
Capsules: Mofetili Mycophenolas 250 mg
APS-Arzneimittel-
Parallelimport-
Service AG
B
FB
G
IP
CI
Cellcept 250 mg
300
k.A.
Capsules: Mofetili Mycophenolas 250 mg
APS-Arzneimittel-
Parallelimport-
Service AG
B
FB
G
IP
CI
Cellcept 250 mg
300
k.A.
Capsules: Mofetili Mycophenolas 250 mg
APS-Arzneimittel-
Parallelimport-
Service AG
B
FB
G
IP
CI
Cellcept 250 mg
300
k.A.
Capsules: Mofetili Mycophenolas 250 mg
APS-Arzneimittel-
Parallelimport-
Service AG
B
FB
G
IP
CI
Cellcept 250 mg
300
k.A.
Capsules: Mofetili Mycophenolas 250 mg
APS-Arzneimittel-
Parallelimport-
Service AG
B
FB
G
IP
CI
Cellcept 250 mg
300
k.A.
Capsules: Mofetili Mycophenolas 250 mg
APS-Arzneimittel-
Parallelimport-
Service AG
B
FB
G
IP
CI
Cellcept 250 mg
300
k.A.
Capsules: Mofetili Mycophenolas 250 mg
APS-Arzneimittel-
Parallelimport-
Service AG
B
FB
G
Leflunomide (L04AA13) 33 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Arava 10 mg
‐
I
30 Tablet(s)
11.81
29.20
10 %
Coated tablets: Leflunomidum 10 mg
Sanofi-Aventis
(Suisse) SA
A / SL / SO
FB
G
IP
CI
Arava 10 mg
‐
I
100 Tablet(s)
39.37
59.05
10 %
Coated tablets: Leflunomidum 10 mg
Sanofi-Aventis
(Suisse) SA
A / SL / SO
FB
G
IP
CI
Arava 20 mg
30 Tablet(s)
20.71
38.85
10 %
Coated tablets: Leflunomidum 20 mg
Sanofi-Aventis
(Suisse) SA
A / SL / SO
FB
G
IP
CI
Arava 20 mg
100 Tablet(s)
69.04
91.20
10 %
Coated tablets: Leflunomidum 20 mg
Sanofi-Aventis
(Suisse) SA
A / SL / SO
FB
G
IP
CI
Arava 100 mg
3 Tablet(s)
12.55
29.95
10 %
Coated tablets: Leflunomidum 100 mg
Sanofi-Aventis
(Suisse) SA
A / SL / SO
FB
G
IP
CI
Leflunomid Gebro 10 mg
3 x 10
10.74
28.10
10 %
Coated tablets: Leflunomidum 10 mg
Gebro Pharma AG
A / SL / SG
FB
G
IP
CI
Leflunomid Gebro 10 mg
10 x 10
35.80
55.40
10 %
Coated tablets: Leflunomidum 10 mg
Gebro Pharma AG
A / SL / SG
FB
G
IP
CI
Leflunomid Gebro 20 mg
3 x 10
18.83
36.90
10 %
Coated tablets: Leflunomidum 20 mg
Gebro Pharma AG
A / SL / SG
FB
G
IP
CI
Leflunomid Gebro 20 mg
10 x 10
62.77
84.75
10 %
Coated tablets: Leflunomidum 20 mg
Gebro Pharma AG
A / SL / SG
FB
G
IP
CI
Leflunomid Sandoz 10
30 Tablet(s)
10.74
28.10
10 %
Coated tablets: Leflunomidum 10 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
Leflunomid Sandoz 10
100 Tablet(s)
35.80
55.40
10 %
Coated tablets: Leflunomidum 10 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
Leflunomid Sandoz 20
30 Tablet(s)
18.83
36.90
10 %
Coated tablets: Leflunomidum 20 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
Leflunomid Sandoz 20
100 Tablet(s)
62.77
84.75
10 %
Coated tablets: Leflunomidum 20 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
Leflunomid Spirig HC 10 mg
30 Tablet(s)
11.30
28.70
10 %
Coated tablets: Leflunomidum 10 mg
Spirig HealthCare AG
A / SL / SG
FB
G
IP
CI
Leflunomid Spirig HC 10 mg
100 Tablet(s)
37.41
57.05
10 %
Coated tablets: Leflunomidum 10 mg
Spirig HealthCare AG
A / SL / SG
FB
G
IP
CI
Leflunomid Spirig HC 20 mg
30 Tablet(s)
19.81
37.90
10 %
Coated tablets: Leflunomidum 20 mg
Spirig HealthCare AG
A / SL / SG
FB
G
IP
CI
Leflunomid Spirig HC 20 mg
100 Tablet(s)
66.03
88.10
10 %
Coated tablets: Leflunomidum 20 mg
Spirig HealthCare AG
A / SL / SG
FB
G
IP
CI
Leflunomid Spirig HC 100 mg
3 Tablet(s)
11.30
28.70
10 %
Coated tablets: Leflunomidum 100 mg
Spirig HealthCare AG
A / SL / SG
FB
G
IP
CI
Leflunomid-Mepha 10
30 Tablet(s)
11.30
28.70
10 %
Coated tablets: Leflunomidum 10 mg
Mepha Pharma AG
A / SL / SG
FB
G
IP
CI
Leflunomid-Mepha 10
100 Tablet(s)
37.42
57.05
10 %
Coated tablets: Leflunomidum 10 mg
Mepha Pharma AG
A / SL / SG
FB
G
IP
CI
Leflunomid-Mepha 20
30 Tablet(s)
19.81
37.90
10 %
Coated tablets: Leflunomidum 20 mg
Mepha Pharma AG
A / SL / SG
FB
G
IP
CI
Leflunomid-Mepha 20
100 Tablet(s)
66.03
88.10
10 %
Coated tablets: Leflunomidum 20 mg
Mepha Pharma AG
A / SL / SG
FB
G
IP
CI
Leflunomide Zentiva 10 mg
30 Tablet(s)
10.75
28.10
10 %
Coated tablets: Leflunomidum 10 mg
Helvepharm AG
A / SL / SG
FB
G
IP
CI
Leflunomide Zentiva 10 mg
100 Tablet(s)
35.83
55.40
10 %
Coated tablets: Leflunomidum 10 mg
Helvepharm AG
A / SL / SG
FB
G
IP
CI
Leflunomide Zentiva 20 mg
30 Tablet(s)
18.83
36.90
10 %
Coated tablets: Leflunomidum 20 mg
Helvepharm AG
A / SL / SG
FB
G
IP
CI
Leflunomide Zentiva 20 mg
100 Tablet(s)
62.77
84.75
10 %
Coated tablets: Leflunomidum 20 mg
Helvepharm AG
A / SL / SG
FB
G
IP
CI
Leflunomide Zentiva 100 mg
3 Tablet(s)
10.75
28.10
10 %
Coated tablets: Leflunomidum 100 mg
Helvepharm AG
A / SL / SG
FB
G
IP
CI
Leflunomid-Mepha 100
3 Tablet(s)
36.78
58.60
k.A.
Coated tablets: Leflunomidum 100 mg
Mepha Pharma AG
A
FB
G
IP
CI
Leflunomid Gebro 10 mg
30 Tablet(s)
16.04
34.80
k.A.
Coated tablets: Leflunomidum 10 mg
Gebro Pharma AG
A
FB
G
IP
CI
Leflunomid Gebro 10 mg
100 Tablet(s)
53.89
78.25
k.A.
Coated tablets: Leflunomidum 10 mg
Gebro Pharma AG
A
FB
G
IP
CI
Leflunomid Gebro 20 mg
30 Tablet(s)
28.13
48.70
k.A.
Coated tablets: Leflunomidum 20 mg
Gebro Pharma AG
A
FB
G
IP
CI
Leflunomid Gebro 20 mg
100 Tablet(s)
98.64
129.65
k.A.
Coated tablets: Leflunomidum 20 mg
Gebro Pharma AG
A
FB
G
IP
CI
Leflunomid Gebro 100 mg
3 Tablet(s)
k.A.
Coated tablets: Leflunomidum 100 mg
Gebro Pharma AG
A
FB
G
Everolimus (L04AA18) 5 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Certican 0.1 mg
60 Tablet(s)
58.26
79.80
10 %
Dispersible Tablets: Everolimusum
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
Certican 0.25 mg
60 Tablet(s)
145.64
174.80
10 %
Tablets: Everolimusum
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
Certican 0.5 mg
60 Tablet(s)
291.27
333.20
10 %
Tablets: Everolimusum
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
Certican 0.75 mg
60 Tablet(s)
436.91
491.60
10 %
Tablets: Everolimusum
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
Certican 1 mg
60 Tablet(s)
582.55
649.95
10 %
Tablets: Everolimusum 1 mg
Novartis Pharma
Schweiz AG
B / SL
FB
G
Abatacept (L04AA24) 3 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
L
IP
CI
Orencia 125 mg/1 ml
4
945.54
1044.75
10 %
Injektionslösung zur subkutanen Anwendung (Fertigpen): Abataceptum 125 mg/ml
Bristol-Myers Squibb SA
B / SL
FB
G
L
IP
CI
Orencia
4 Fertigspritze(n)
945.54
1044.75
10 %
Injektionslösung zur subkutanen Anwendung (Fertigspritze mit Nadelschutz): Abataceptum 125 mg/ml
Bristol-Myers Squibb SA
B / SL
FB
G
L
SIP
IP
Orencia 250 mg
Durchstechflasche(n)
344.08
390.60
10 %
Pulver zur Herstellung eines Infusionslösungkonzentrats: Abataceptum 250 mg
Bristol-Myers Squibb SA
A / SL
FB
G
Fingolimod (L04AA27) 12 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
L
IP
CI
Fingolimod Devatis 0.5 mg
28
380.52
430.25
10 %
Capsules: Fingolimodum
Devatis AG
B / SL / SG
FB
G
L
IP
CI
Fingolimod Devatis 0.5 mg
98
1331.83
1464.85
10 %
Capsules: Fingolimodum
Devatis AG
B / SL / SG
FB
G
L
IP
CI
CM
Fingolimod Sandoz 0.5 mg
28
380.52
430.25
10 %
Capsules: Fingolimodum
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
CM
Fingolimod Sandoz 0.5 mg
98
1331.83
1464.85
10 %
Capsules: Fingolimodum
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Fingolimod Viatris 0,5 mg
28
380.52
430.25
10 %
Capsules: Fingolimodum
Viatris Pharma GmbH
B / SL / SG
FB
G
L
IP
CI
Fingolimod Viatris 0,5 mg
98
1331.83
1464.85
10 %
Capsules: Fingolimodum
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CI
Fingolimod Devatis 0.25 mg
7
k.A.
Capsules: Fingolimodum
Devatis AG
B
FB
G
IP
CI
Fingolimod Devatis 0.25 mg
28
k.A.
Capsules: Fingolimodum
Devatis AG
B
FB
G
IP
CI
Fingolimod Devatis 0.5 mg
7
k.A.
Capsules: Fingolimodum
Devatis AG
B
FB
G
IP
CI
Fingolimod Devatis 0.5 mg
84
k.A.
Capsules: Fingolimodum
Devatis AG
B
FB
G
IP
CI
CM
Fingolimod Sandoz 0.25 mg
7
k.A.
Capsules: Fingolimodum
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
CM
Fingolimod Sandoz 0.25 mg
28
k.A.
Capsules: Fingolimodum
Sandoz
Pharmaceuticals AG
B
FB
G
Belatacept (L04AA28) 2 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
L
IP
PP
Nulojix 250 mg
391.50
442.20
10 %
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Belataceptum 250 mg
Bristol-Myers Squibb SA
A / SL
FB
G
L
IP
PP
Nulojix 250 mg
2
783.00
868.00
10 %
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Belataceptum 250 mg
Bristol-Myers Squibb SA
A / SL
FB
G
Apremilast (L04AA32) 15 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
L
IP
CI
Otezla 30mg
56 Tablet(s)
292.31
334.85
10 %
Coated tablets: Apremilastum 30 mg
Amgen Switzerland AG
B / SL / SO
FB
G
L
IP
CI
Otezla 10 mg, 20 mg
19 Tablet(s)
138.01
166.75
10 %
mg: Apremilastum 10 mg
mg: Apremilastum 20 mg
mg: Apremilastum 30 mg
Amgen Switzerland AG
B / SL / SO
FB
G
L
IP
CI
Apremilast Leman 30 mg
56
240.00
281.15
10 %
Coated tablets: Apremilastum 30 mg
Leman SKL SA
B / SL / SG
FB
G
L
IP
CI
Apremilast Spirig HC 30 mg
56
280.98
323.20
10 %
Coated tablets: Apremilastum 30 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Apremilast Spirig HC 30 mg
168
716.49
795.65
10 %
Coated tablets: Apremilastum 30 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Apremilast Spirig HC 10 mg / 20 mg / 30 mg
4 + 19
132.97
161.60
10 %
Coated tablets: Apremilastum 10 mg
Coated tablets: Apremilastum 20 mg
Coated tablets: Apremilastum 30 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Apremilast-Mepha 30 mg
56
280.98
323.20
10 %
Coated tablets: Apremilastum 30 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Apremilast Leman 10 mg, 20 mg
4 + 19
113.00
141.10
10 %
mg: Apremilastum 10 mg
mg: Apremilastum 20 mg
mg: Apremilastum 30 mg
Leman SKL SA
B / SL / SG
FB
G
L
IP
CI
Apremilast-Mepha 10 mg, 20 mg
4 + 19
132.97
161.60
10 %
mg Filmtabletten: Apremilastum 10 mg
mg Filmtabletten: Apremilastum 20 mg
mg Filmtabletten: Apremilastum 30 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Apremilast Leman
k.A.
Leman SKL SA
FB
G
L
IP
CI
Apremilast Devatis 30 mg
56
280.98
323.20
10 %
Coated tablets: Apremilastum 30 mg
Devatis AG
B / SL / SG
FB
G
L
IP
CI
Apremilast Devatis 10 mg, 20 mg
4 + 19
132.97
161.60
10 %
mg: Apremilastum 10 mg
mg: Apremilastum 20 mg
mg: Apremilastum 30 mg
Devatis AG
B / SL / SG
FB
G
IP
CI
Apremilast Leman 30 mg
168
k.A.
Coated tablets: Apremilastum 30 mg
Leman SKL SA
B
FB
G
Apremilast Sandoz 30 mg
56
k.A.
Coated tablets: Apremilastum 30 mg
Sandoz
Pharmaceuticals AG
B
FB
G
Apremilast Sandoz 10 mg, 20 mg
4 + 19
k.A.
mg: Apremilastum 10 mg
mg: Apremilastum 20 mg
mg: Apremilastum 30 mg
Sandoz
Pharmaceuticals AG
B
FB
G
Alemtuzumab (L04AA34) 1 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
L
IP
CI
Lemtrada 10 mg/ml
Durchstechflasche(n)
6740.57
7223.60
10 %
Concentrate for infusion: Alemtuzumabum 12mg / 1.2ml
Sanofi-Aventis
(Suisse) SA
A / SL
FB
G
Baricitinib (L04AA37) 2 products
WHO-DDD
Page 1 of 2:
1
2
>>
L
IP
CI
PP
Olumiant 2 mg
28
871.24
963.95
10 %
Coated tablets: Baricitinibum 2 mg
Eli Lilly (Suisse) SA
B / SL
FB
G
L
IP
CI
PP
Olumiant 4 mg
28
871.24
963.95
10 %
Coated tablets: Baricitinibum 4 mg
Eli Lilly (Suisse) SA
B / SL
FB
G
Cladribine (L04AA40) 3 products
WHO-DDD
Page 1 of 2:
1
2
>>
L
IP
CI
Mavenclad 10 mg
2348.19
2570.20
10 %
Tablets: Cladribinum 10 mg
Merck (Schweiz) AG
A / SL
FB
G
L
IP
CI
Mavenclad 10 mg
4
9392.76
9944.75
10 %
Tablets: Cladribinum 10 mg
Merck (Schweiz) AG
A / SL
FB
G
L
IP
CI
Mavenclad 10 mg
6
14089.14
14763.25
10 %
Tablets: Cladribinum 10 mg
Merck (Schweiz) AG
A / SL
FB
G
Imlifidase (L04AA41) 2 products
WHO-DDD
Page 1 of 2:
1
2
>>
L
IP
Idefirix 11 mg
+ +
137798.05
141688.60
10 %
poudre pour solution à diluer pour perfusion: Imlifidasum 11 mg
iQone Healthcare
Switzerland SA
A / SL
FB
G
IP
Idefirix 11 mg
2
k.A.
poudre pour solution à diluer pour perfusion: Imlifidasum 11 mg
iQone Healthcare
Switzerland SA
A
FB
G
Inebilizumab (L04AA47) 1 products
WHO-DDD
Page 1 of 2:
1
2
>>
IP
Uplizna 100 mg/10ml
3
k.A.
Concentrate for infusion: Inebilizumabum 100mg / 10ml
Amgen Switzerland AG
A
FB
G
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home
